These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 33905739)
1. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739 [TBL] [Abstract][Full Text] [Related]
2. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection. Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Mulay A; Konda B; Garcia G; Yao C; Beil S; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR bioRxiv; 2020 Jun; ():. PubMed ID: 32637946 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response. Huang J; Hume AJ; Abo KM; Werder RB; Villacorta-Martin C; Alysandratos KD; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Olejnik J; Suder EL; Bullitt E; Hinds A; Sharma A; Bosmann M; Wang R; Hawkins F; Burks EJ; Saeed M; Wilson AA; Mühlberger E; Kotton DN Cell Stem Cell; 2020 Dec; 27(6):962-973.e7. PubMed ID: 32979316 [TBL] [Abstract][Full Text] [Related]
6. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing. Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994 [TBL] [Abstract][Full Text] [Related]
7. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. Fiege JK; Thiede JM; Nanda HA; Matchett WE; Moore PJ; Montanari NR; Thielen BK; Daniel J; Stanley E; Hunter RC; Menachery VD; Shen SS; Bold TD; Langlois RA PLoS Pathog; 2021 Jan; 17(1):e1009292. PubMed ID: 33507952 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646 [TBL] [Abstract][Full Text] [Related]
9. Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure. Murthy A; Rodriguez LR; Dimopoulos T; Bui S; Iyer S; Chavez K; Tomer Y; Abraham V; Cooper C; Renner DM; Katzen JB; Bentley ID; Ghadiali SN; Englert JA; Weiss SR; Beers MF Am J Physiol Lung Cell Mol Physiol; 2024 Aug; 327(2):L232-L249. PubMed ID: 38860845 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Modeling of SARS-CoV-2 Infection of Hao S; Ning K; Kuz CA; Vorhies K; Yan Z; Qiu J mBio; 2020 Nov; 11(6):. PubMed ID: 33158999 [TBL] [Abstract][Full Text] [Related]
11. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT mBio; 2021 Jan; 12(1):. PubMed ID: 33468703 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2. Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278 [TBL] [Abstract][Full Text] [Related]
13. Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids. Krüger J; Groß R; Conzelmann C; Müller JA; Koepke L; Sparrer KMJ; Weil T; Schütz D; Seufferlein T; Barth TFE; Stenger S; Heller S; Münch J; Kleger A Cell Mol Gastroenterol Hepatol; 2021; 11(4):935-948. PubMed ID: 33186749 [TBL] [Abstract][Full Text] [Related]
14. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. Lamers MM; van der Vaart J; Knoops K; Riesebosch S; Breugem TI; Mykytyn AZ; Beumer J; Schipper D; Bezstarosti K; Koopman CD; Groen N; Ravelli RBG; Duimel HQ; Demmers JAA; Verjans GMGM; Koopmans MPG; Muraro MJ; Peters PJ; Clevers H; Haagmans BL EMBO J; 2021 Mar; 40(5):e105912. PubMed ID: 33283287 [TBL] [Abstract][Full Text] [Related]
15. Halting SARS-CoV-2: lung organoids step up to the plate. Leibel SL; Sun X EMBO J; 2021 Mar; 40(5):e107651. PubMed ID: 33576058 [TBL] [Abstract][Full Text] [Related]
16. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797 [TBL] [Abstract][Full Text] [Related]
17. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants. Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770 [TBL] [Abstract][Full Text] [Related]
18. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models. Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962 [TBL] [Abstract][Full Text] [Related]